Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.07B |
| 2 |
Exxon Mobil
XOM
|
+$596M |
| 3 |
Merck
MRK
|
+$552M |
| 4 |
MetLife
MET
|
+$377M |
| 5 |
Walmart
WMT
|
+$355M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$1B |
| 2 |
TSMC
TSM
|
+$635M |
| 3 |
AbbVie
ABBV
|
+$604M |
| 4 |
Cisco
CSCO
|
+$525M |
| 5 |
Goldman Sachs
GS
|
+$481M |
Sector Composition
| 1 | Technology | 27.89% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.44% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Industrials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
iRobot
IRBT
$107M
| $956K | ﹤0.01% |
123,400
-1,704
| -1% | -$13.2K |
|
|
EARN
3152
Ellington Residential Mortgage REIT
EARN
$213M
| $955K | ﹤0.01% |
+144,217
| New | +$955K |
|
3153
Sleep Number
SNBR
$211M
| $949K | ﹤0.01% |
62,247
-326
| -0.5% | -$4.97K |
|
3154
Sensus Healthcare
SRTS
$52.6M
| $946K | ﹤0.01% |
136,682
+408
| +0.3% | +$2.82K |
|
3155
Akebia Therapeutics
AKBA
$777M
| $945K | ﹤0.01% |
497,547
+27,839
| +6% | +$52.9K |
|
3156
Montauk Renewables
MNTK
$290M
| $945K | ﹤0.01% |
237,394
+20,562
| +9% | +$81.8K |
|
3157
Grindr
GRND
$2.96B
| $944K | ﹤0.01% |
52,887
+623
| +1% | +$11.1K |
|
3158
iQIYI
IQ
$2.5B
| $943K | ﹤0.01% |
469,193
-333,157
| -42% | -$670K |
|
3159
Bankwell Financial Group
BWFG
$350M
| $943K | ﹤0.01% |
30,262
+7,908
| +35% | +$246K |
|
|
PSTL
3160
Postal Realty Trust
PSTL
$392M
| $942K | ﹤0.01% |
72,179
-40,705
| -36% | -$531K |
|
3161
Definitive Healthcare
DH
$414M
| $942K | ﹤0.01% |
229,143
+60,559
| +36% | +$249K |
|
3162
Esperion Therapeutics
ESPR
$524M
| $941K | ﹤0.01% |
427,532
+1,758
| +0.4% | +$3.87K |
|
|
NAGE
3163
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $939K | ﹤0.01% |
176,976
+21,734
| +14% | +$115K |
|
3164
Treace Medical Concepts
TMCI
$442M
| $937K | ﹤0.01% |
125,945
+3,215
| +3% | +$23.9K |
|
3165
SkyWater Technology
SKYT
$474M
| $937K | ﹤0.01% |
67,891
+11,800
| +21% | +$163K |
|
|
PHX
3166
DELISTED
PHX Minerals
PHX
| $936K | ﹤0.01% |
233,967
-51,074
| -18% | -$204K |
|
|
RVNC
3167
DELISTED
Revance Therapeutics, Inc.
RVNC
| $936K | ﹤0.01% |
307,764
-18,519
| -6% | -$56.3K |
|
3168
Electromed
ELMD
$197M
| $934K | ﹤0.01% |
31,615
+22,200
| +236% | +$656K |
|
|
SAGE
3169
DELISTED
Sage Therapeutics
SAGE
| $931K | ﹤0.01% |
171,444
-9,655
| -5% | -$52.4K |
|
3170
Pulmonx
LUNG
$65.6M
| $920K | ﹤0.01% |
135,440
+64
| +0% | +$435 |
|
3171
OmniAb
OABI
$226M
| $917K | ﹤0.01% |
259,171
-63,047
| -20% | -$223K |
|
3172
RE/MAX Holdings
RMAX
$187M
| $912K | ﹤0.01% |
85,505
+18,300
| +27% | +$195K |
|
3173
Prudential
PUK
$35.5B
| $908K | ﹤0.01% |
56,990
-15,450
| -21% | -$246K |
|
3174
Boston Omaha
BOC
$421M
| $906K | ﹤0.01% |
63,886
+158
| +0.2% | +$2.24K |
|
3175
Zevra Therapeutics
ZVRA
$448M
| $905K | ﹤0.01% |
108,487
-37,365
| -26% | -$312K |
|